Lv1
78 积分 2021-03-04 加入
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China
4小时前
待确认
Chimeric design of pyrrolysyl-tRNA synthetase/tRNA pairs and canonical synthetase/tRNA pairs for genetic code expansion
5个月前
已完结
Rare codon recoding for efficient noncanonical amino acid incorporation in mammalian cells
5个月前
已完结
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
6个月前
已完结
When will we have a clone? An industry perspective on the typical CLD timeline
6个月前
已完结
A Review on the Current Methods of Chinese Hamster Ovary (CHO) Cells Cultivation for the Production of Therapeutic Protein
6个月前
已完结
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial
7个月前
已完结
Draft Document for Public Consultation: 28 iCARDIO Alliance Global Implementation Guidelines 29 on Obesity Management 2025
7个月前
已完结
皖公网安备34019202002308
